Among the different CD8+ T-LGL leukemia immunophenotypic combinations, patients characterized by CD16+/CD56- proliferating cells showed the highest frequency of STAT3 mutations. This evidence concerns the gene STAT3 and T-cell large granular lymphocyte leukemia.